AMTEK, Inc. (AME) Rating Increased to Overweight at Atlantic Securities

AMTEK, Inc. (NYSE:AME) was upgraded by Atlantic Securities from a “neutral” rating to an “overweight” rating in a research report issued to clients and investors on Wednesday. The firm currently has a $62.00 price target on the stock. Atlantic Securities’ price objective would indicate a potential upside of 15.71% from the stock’s previous close.

AME has been the topic of a number of other reports. RBC Capital Markets reissued an “outperform” rating and issued a $57.00 price target (down from $59.00) on shares of AMTEK in a research report on Wednesday, November 2nd. Royal Bank Of Canada boosted their price target on AMTEK from $57.00 to $60.00 and gave the stock an “outperform” rating in a research report on Wednesday, February 8th. Robert W. Baird raised AMTEK from a “neutral” rating to an “outperform” rating and boosted their price target for the stock from $47.00 to $57.00 in a research report on Thursday, December 22nd. Janney Montgomery Scott started coverage on AMTEK in a research report on Monday, October 24th. They issued a “buy” rating and a $56.00 price objective on the stock. Finally, Zacks Investment Research raised AMTEK from a “sell” rating to a “hold” rating in a research report on Wednesday, November 2nd. One investment analyst has rated the stock with a hold rating and eleven have given a buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $55.36.

Analyst Recommendations for AMTEK (NYSE:AME)

AMTEK (NYSE:AME) opened at 53.58 on Wednesday. The firm has a 50-day moving average price of $50.91 and a 200 day moving average price of $48.41. AMTEK has a one year low of $43.28 and a one year high of $53.89. The company has a market cap of $12.33 billion, a price-to-earnings ratio of 24.47 and a beta of 1.11.

AMTEK (NYSE:AME) last issued its quarterly earnings results on Tuesday, February 7th. The company reported $0.58 EPS for the quarter, topping analysts’ consensus estimates of $0.58 by $0.00. AMTEK had a return on equity of 16.19% and a net margin of 13.34%. The firm had revenue of $973 million for the quarter, compared to analysts’ expectations of $969.84 million. During the same period in the previous year, the firm posted $0.63 EPS. The business’s revenue for the quarter was down 1.5% compared to the same quarter last year. Equities analysts expect that AMTEK will post $2.44 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 31st. Stockholders of record on Friday, March 17th will be paid a $0.09 dividend. The ex-dividend date is Wednesday, March 15th. This represents a $0.36 annualized dividend and a dividend yield of 0.67%. AMTEK’s dividend payout ratio (DPR) is 16.44%.

This article was originally published by BBNS and is owned by of BBNS. If you are viewing this article on another site, it was stolen and reposted in violation of U.S. & international copyright & trademark legislation. The legal version of this article can be accessed at https://baseballnewssource.com/markets/amtek-inc-ame-rating-increased-to-overweight-at-atlantic-securities/434951.html.

In other news, insider Frank S. Hermance sold 335,790 shares of the company’s stock in a transaction on Monday, February 13th. The stock was sold at an average price of $53.66, for a total value of $18,018,491.40. Following the completion of the sale, the insider now directly owns 386,429 shares in the company, valued at approximately $20,735,780.14. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Elizebeth R. Varet sold 4,000 shares of the company’s stock in a transaction on Friday, December 16th. The stock was sold at an average price of $49.22, for a total value of $196,880.00. Following the completion of the sale, the director now owns 123,840 shares of the company’s stock, valued at $6,095,404.80. The disclosure for this sale can be found here. Insiders sold a total of 345,223 shares of company stock valued at $18,505,928 over the last 90 days. 2.00% of the stock is currently owned by company insiders.

Several large investors have recently bought and sold shares of the company. State Street Corp raised its stake in AMTEK by 5.3% in the fourth quarter. State Street Corp now owns 9,571,155 shares of the company’s stock valued at $465,162,000 after buying an additional 479,261 shares during the period. BlackRock Institutional Trust Company N.A. raised its stake in AMTEK by 1.9% in the third quarter. BlackRock Institutional Trust Company N.A. now owns 6,038,206 shares of the company’s stock valued at $288,505,000 after buying an additional 114,944 shares during the period. JPMorgan Chase & Co. increased its position in shares of AMTEK by 8.3% in the third quarter. JPMorgan Chase & Co. now owns 4,856,543 shares of the company’s stock valued at $232,046,000 after buying an additional 372,809 shares in the last quarter. BlackRock Fund Advisors increased its position in shares of AMTEK by 4.0% in the third quarter. BlackRock Fund Advisors now owns 3,805,242 shares of the company’s stock valued at $181,814,000 after buying an additional 144,631 shares in the last quarter. Finally, Janus Capital Management LLC increased its position in shares of AMTEK by 166.3% in the fourth quarter. Janus Capital Management LLC now owns 3,749,860 shares of the company’s stock valued at $182,282,000 after buying an additional 2,341,543 shares in the last quarter. Hedge funds and other institutional investors own 89.39% of the company’s stock.

About AMTEK

AMETEK, Inc (AMETEK) is a manufacturer of electronic instruments and electromechanical devices. The Company operates through two segments: Electronic Instruments (EIG) and Electromechanical (EMG). EIG designs and manufactures advanced instruments for the process, aerospace, power and industrial markets.

5 Day Chart for NYSE:AME

Receive News & Ratings for AMTEK Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMTEK Inc. and related companies with our FREE daily email newsletter.

 

Latest News

Alex Rodriguez: No Comeback for Me
Alex Rodriguez: No Comeback for Me
Cleveland Indians Moving Along Slowly with Corey Kluber
Cleveland Indians Moving Along Slowly with Corey Kluber
Garrett Richards Returns Without Tommy John Surgery
Garrett Richards Returns Without Tommy John Surgery
Chris Tillman Injury Will Test Rotation Depth with Orioles
Chris Tillman Injury Will Test Rotation Depth with Orioles
Brandon Phillips Traded to Atlanta by Cincinnati
Brandon Phillips Traded to Atlanta by Cincinnati
Rumor: Miami Marlins Reach Tentative Agreement to Sell
Rumor: Miami Marlins Reach Tentative Agreement to Sell


Leave a Reply

 
© 2006-2017 BBNS.